These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19303253)

  • 1. Hepatocellular carcinomas: correlation between time to peak hepatocellular carcinomas enhancement and time to peak aortic enhancement.
    Sun X; Liu C; Liang C; Sun C; Liu S; Deng K
    Comput Med Imaging Graph; 2009 Jun; 33(4):312-6. PubMed ID: 19303253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
    Ma X; Samir AE; Holalkere NS; Sahani DV
    AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
    Awai K; Takada K; Onishi H; Hori S
    Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT.
    Marin D; Catalano C; De Filippis G; Di Martino M; Guerrisi A; Rossi M; Passariello R
    AJR Am J Roentgenol; 2009 Jan; 192(1):180-7. PubMed ID: 19098199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiphase contrast-enhanced CT imaging in hepatocellular carcinoma correlation with immunohistochemical angiogenic activities.
    Kim YI; Chung JW; Park JH; Kang GH; Lee M; Suh KS; Kim KG
    Acad Radiol; 2007 Sep; 14(9):1084-91. PubMed ID: 17707316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
    Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma.
    Gordic S; Puippe GD; Krauss B; Klotz E; Desbiolles L; Lesurtel M; Müllhaupt B; Pfammatter T; Alkadhi H
    Radiology; 2016 Jul; 280(1):78-87. PubMed ID: 26824712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging.
    Sultana S; Awai K; Nakayama Y; Nakaura T; Liu D; Hatemura M; Funama Y; Morishita S; Yamashita Y
    Radiology; 2007 Apr; 243(1):140-7. PubMed ID: 17329690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of a fixed scan delay technique using a previous bolus tracking technique data for dynamic hepatic CT.
    Takumi K; Fukukura Y; Shindo T; Kumagae Y; Tateyama A; Kamiyama T; Nakajo M
    Eur J Radiol; 2012 Nov; 81(11):2996-3001. PubMed ID: 22749800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging.
    Monzawa S; Ichikawa T; Nakajima H; Kitanaka Y; Omata K; Araki T
    AJR Am J Roentgenol; 2007 Jan; 188(1):147-53. PubMed ID: 17179357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of variability in breath-hold perfusion CT of hepatocellular carcinoma: a step toward clinical use.
    Petralia G; Summers P; Viotti S; Montefrancesco R; Raimondi S; Bellomi M
    Radiology; 2012 Nov; 265(2):448-56. PubMed ID: 22996748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing scan timing of hepatic arterial phase by physiologic pharmacokinetic analysis in bolus-tracking technique by multi-detector row computed tomography.
    Yamaguchi I; Kidoya E; Suzuki M; Kimura H
    Radiol Phys Technol; 2011 Jan; 4(1):43-52. PubMed ID: 20872188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose modulated retrospective ECG-gated versus non-gated 64-row CT angiography of the aorta at the same radiation dose: comparison of motion artifacts, diagnostic confidence and signal-to-noise-ratios.
    Schernthaner RE; Stadler A; Beitzke D; Homolka P; Weber M; Lammer J; Czerny M; Loewe C
    Eur J Radiol; 2012 Apr; 81(4):e585-90. PubMed ID: 21820829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
    Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiphase Multi-Detector Row Computed Tomography Imaging Characteristics of Large (>5 cm) Focal Hepatocellular Carcinoma.
    Blaschke EM; Rao VL; Xiong L; Te HS; Hart J; Reddy KG; Oto A
    J Comput Assist Tomogr; 2016; 40(3):493-7. PubMed ID: 26953766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Miyoshi T; Nishibori H; Kato H; Hoshi H; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2006 Jul; 187(1):W25-32. PubMed ID: 16794136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma.
    Kim KW; Lee JM; Klotz E; Park HS; Lee DH; Kim JY; Kim SJ; Kim SH; Lee JY; Han JK; Choi BI
    Radiology; 2009 Feb; 250(2):425-434. PubMed ID: 19188314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
    Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques.
    Galizia MS; Töre HG; Chalian H; McCarthy R; Salem R; Yaghmai V
    Acad Radiol; 2012 Jan; 19(1):48-54. PubMed ID: 22054801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.